Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Pain assessment is one of medicine's toughest challenges when patients can't self-report. From premature infants to dementia patients, clinicians often miss suffering hidden behind behavioral cues. Emerging tools like AI-driven facial analysis and biomarker research offer promise, but experts say the biggest barrier remains time and training — not technology.
Pain is the only vital sign without a universal objective measure — and for patients who can't speak for themselves, that gap can mean real suffering goes unrecognized. Premature infants, children with autism or intellectual disabilities, adolescents with chronic pain, and dementia patients all face a common problem: their pain signals don't come in words. Instead, they show up as a furrowed brow, a refusal to walk, a sleepless night, or unexpected irritability — cues that are easy to miss or misattribute.
The stakes are high. Repeated painful procedures in neonatal ICUs without adequate pain management can affect neurological development. In dementia patients, an estimated 40–80% experience regular pain, yet it's frequently attributed to disease progression rather than a treatable cause. And for adolescents with chronic pain, being disbelieved can be just as disabling as the pain itself.
By the Numbers
Why it matters: Technology — from pupil-tracking devices like the Nociometer to AI-powered facial expression analysis — is advancing fast. But a 2025 review in BMC Anesthesiology found the biggest obstacles aren't technological: they're lack of training, poor protocol implementation, and limited clinical time. Better tools matter, but so does having the time to actually use them.